PTPN6 and nonpapillary renal cell carcinoma: The phosphorylation from UALCAN dataset indicated that significantly altered ptpn6 phosphorylation levels were observed in 6 tumors, including clear cell RCC (CCRCC), LUAD, HNSC, PAAD, colon cancer (CC) and LUSC, and the changes were mainly distributed in three sites, including S10, Y564 and S140 (Fig. 8).